Browse practical guidance on privacy-safe healthcare advertising, analytics, patient acquisition, and marketing compliance.
Hospital systems have paid millions to settle pixel-related class actions in the past two years, and plaintiffs' experts have identified at least 664 hospital or medical provider web propert
Read articleHealthcare marketers asking "how long until we're compliant?" are usually shocked by the answer. A solo dermatology practice and a 40-location surgical group both need Meta's Conversions API
Read articleHealthcare marketing teams are caught between two pressures: aggressive patient acquisition goals and an enforcement environment where a single misconfigured pixel can trigger seven-figure l
Read articleHealthcare advertisers face a brutal math problem. Client-side pixels leak a significant share of conversion data to browser restrictions while simultaneously exposing practices to seven-fig
Read articleBehavioral health practices commonly pay four-figure sums to acquire a single patient, while the average med spa spends roughly $132 in new-patient acquisition cost against a $527 average vi
Read articleA pediatric appointment-booking page can quietly transmit a child's IP address, the parent's email, and a condition-specific URL like /adhd-evaluation to Meta or Google within milliseconds o
Read articleAdvocate Aurora Health agreed to pay $12.2 million to settle allegations it disclosed the personal health information of more than 2.5 million patients to Meta and Google through tracking pi
Read articleCancer patients spend months researching before they ever pick up the phone. CAPI oncology implementations have to account for that reality: a single new-patient acquisition typically involv
Read articlePlastic surgery sits at the intersection of two punishing realities for paid search: it is one of the most expensive verticals in Google Ads, and it is one of the most heavily restricted. Go
Read articleOn March 3, 2026, the FDA issued 30 warning letters to telehealth companies for false or misleading claims about compounded GLP-1 products, a clear signal that state pharmacy board GLP-1 ove
Read articleOn March 3, 2026, the FDA issued 30 warning letters in a single day to telehealth companies marketing compounded GLP-1 products, the second large batch since a September 2025 crackdown began
Read articleHeart disease remains the leading cause of death in the United States, with [1]919,032 people dying from cardiovascular disease in 2023, the equivalent of 1 in every 3 deaths. For cardiology
Read articlePatients who stop GLP-1 receptor agonists after hitting their goal weight face a steep biological cliff. [1] In the STEP 1 extension trial, participants regained roughly two-thirds of their
Read articleOn September 9, 2025, the FDA issued a warning letter to Eli Lilly over a high-profile Oprah Winfrey television special that promoted Zepbound and Mounjaro. [1]The FDA determined the promoti
Read articleNovo Nordisk's November 2025 announcement of cash pricing for Ozempic and Wegovy didn't just reshape consumer access; it reshaped the B2B funnel. [1] Patients searching for the discount now
Read articleOn March 3, 2026, the FDA made public 30 warning letters sent February 20 to telehealth companies for "false or misleading claims" about compounded GLP-1 products, with Commissioner Marty Ma
Read articleNearly half of patients starting GLP-1 receptor agonists for weight loss stop taking them within twelve months. [1] In a cohort study of 125,474 patients initiating GLP-1 medications, 46.5%
Read articleRoughly 2 in 3 newly eligible US adults aged 45 to 49 have never been screened for colorectal cancer, based on 2022 Behavioral Risk Factor Surveillance System data published by the CDC.[1] F
Read articleAn estimated [1] 85.6 million U.S. adults have obstructive sleep apnea, yet roughly 80% remain undiagnosed, representing one of the largest unmet patient demand pools in American healthcare.
Read articleFoot pain drives urgent search behavior, and the practice that captures that high-intent click usually wins the appointment. Yet podiatry groups running google ads podiatry campaigns face a
Read articleOBGYN practices occupy one of the most heavily regulated corners of digital advertising. Between Google's restrictions on birth control, fertility, and abortion-related queries, and the post
Read articleAudiology practices face a paradox heading into 2026: demand has never been higher, yet competition for qualified hearing aid patients has never been fiercer. [1] With roughly 15% of America
Read articleHome health is one of the fastest-growing care segments in the United States, and agencies running paid search campaigns across multiple state lines face a compliance problem that simpler he
Read articleHospice marketing sits at a uniquely sensitive intersection: families researching end-of-life care for a loved one are often in crisis, and the federal government is paying close attention t
Read article